From advancements in cancer therapy to detecting cardiac issues with Artificial Intelligence, Westchester has emerged as the mecca of life sciences in New York State. Innovative companies are both opening and relocating their headquarters to the area, with the county now responsible for at least 20% of New York State’s life-sciences jobs.
The roots of this bustling biotech arena can be traced back to the early 1900s, when the county bought the Grasslands Reservation in Valhalla — now home to New York Medical College — from the Hammond family in 1915. Westchester County allowed the U.S. Army to treat soldiers recovering from World War I wounds and the influenza outbreak at the early hospital grounds.
The Need for Space
In the century since, more than 200 bioscience companies have settled in the area. The allure of setting up shop just north of New York City is thanks, in part, to the amount of space that Westchester offers for unique types of research and development.
“In New York City, you have narrow buildings, and most of the laboratory space is in the basement,” says Eric Feinstein, president and CEO of Clarapath Pathology, a Hawthorne-based company advancing the way tissue is examined in biopsies. “We’re a precision manufacturing business combined with a laboratory, so it’s a unique combination that requires a certain amount of space.”
Using a good portion of space in the Eastview area of Greenburgh adjacent to the Tarrytown Lakes is the pharmaceutical giant Regeneron, whose campus is in the process of a 724,000-square-foot expansion.
The company, which explores a range of research — from genome sequencing to immuno-oncology drugs — is home to the Regeneron Genetics Center (RGC). The Center boasts some of the most advanced technology in the country for sequencing, allowing researchers to study tens of millions of genomes in a single tissue to identify new treatment efforts and invent life-transforming medicines for disease.